Connor, Clark & Lunn Investment Management (CC&L)’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-6,500	Closed	-$603K	–	653
2014 Q4	$603K	Buy	6,500 +700	+12%	+$64.9K	﹤0.01%	364
2014 Q3	$399K	Buy	+5,800	New	+$399K	﹤0.01%	420